Leading Pharmaceutical Operational Excellence [electronic resource] : Outstanding Practices and Cases / edited by Thomas Friedli, Prabir Basu, Daniel Bellm, Jürgen Werani.

Contributor(s):

Material type: Text

TextPublisher: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2013Description: IX, 541 p. 263 illus. online resourceContent type:

text

Media type:

computer

Carrier type:

online resource

ISBN:

9783642351617

Subject(s):

Additional physical formats: Printed edition:: No titleDDC classification:

658.5 23

LOC classification:

TS155-TS194

Online resources:

Click here to access online

Contents:

Part A - Introduction -- Part B - Leading Operational Excellence - Outstanding Practices -- Part C - Leading Operational Excellence - Outstanding Leadership -- Part D - Gaining the Future.

In: Springer eBooksSummary: Achieving operational excellence is a challenge for the pharmaceutical industry, with many companies setting successful examples time and again. This book presents such leading practices for managing operational excellence throughout the pharmaceutical industry. Based on the St.Gallen OPEX Model the authors describe the current status of OPEX and the future challenges that have to be dealt with. The ample theoretical background is complemented hand-in-hand by case studies contributed by authors from leading pharmaceutical companies.

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Part A - Introduction -- Part B - Leading Operational Excellence - Outstanding Practices -- Part C - Leading Operational Excellence - Outstanding Leadership -- Part D - Gaining the Future.

Achieving operational excellence is a challenge for the pharmaceutical industry, with many companies setting successful examples time and again. This book presents such leading practices for managing operational excellence throughout the pharmaceutical industry. Based on the St.Gallen OPEX Model the authors describe the current status of OPEX and the future challenges that have to be dealt with. The ample theoretical background is complemented hand-in-hand by case studies contributed by authors from leading pharmaceutical companies.

There are no comments on this title.

to post a comment.